B7-33 is actively being studied for its impressive anti-fibrotic properties. Researchers are exploring its potential to combat fibrosis in various conditions, including heart failure, lung inflammation, and kidney diseases, among others. In animal-based research, B7-33 has demonstrated a reduction in fibrosis by approximately 50%, offering a significant extension in survival post-injury. This makes it a potential breakthrough in heart failure treatments, a field that hasn't seen major advancements in the past two decades. Furthermore, B7-33 has displayed potential in limiting excessive scar formation after cardiac injuries. Its benefits also extend to certain vascular conditions and might even play a role in addressing preeclampsia during pregnancy.

Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals.